The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Development of a highly efficacious, first-in-class antibody-drug conjugate against a novel MUC1-C oncoprotein for metastatic colorectal cancer.
 
Deepak Raina
Employment - XYone Therapeutics
Stock and Other Ownership Interests - XYone Therapeutics
Research Funding - XYone Therapeutics
Travel, Accommodations, Expenses - XYone Therapeutics
 
Govind Panchamoorthy
Employment - XYone Therapeutics
Stock and Other Ownership Interests - XYone Therapeutics
Research Funding - XYone Therapeutics
Patents, Royalties, Other Intellectual Property - XYone Therapeutics
Travel, Accommodations, Expenses - XYone Therapeutics
 
Rehan Ahmad
Employment - XYone Therapeutics
Stock and Other Ownership Interests - XYone Therapeutics
Research Funding - XYone Therapeutics
Travel, Accommodations, Expenses - XYone Therapeutics
 
Ravi Jasuja
Employment - FPT LLC
Leadership - Founder, XYone Therapeutics
Stock and Other Ownership Interests - Founder, FPT LLC; Founder, XYone Therapeutics
Research Funding - FPT LLC; XYone Therapeutics
Patents, Royalties, Other Intellectual Property - FPT LLC
Travel, Accommodations, Expenses - FPT LLC; XYone Therapeutics
 
Surender Kharbanda
Employment - XYone Therapeutics
Stock and Other Ownership Interests - Tharimmune; XYone Therapeutics
Consulting or Advisory Role - Gibson Oncology; Tharimmune
Research Funding - XYone Therapeutics
Patents, Royalties, Other Intellectual Property - Tharimmune; XYone Therapeutics
Travel, Accommodations, Expenses - XYone Therapeutics